Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12290651
Devices and methods for the treatment of body surface disorders
granted -
US 12290567
Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugates
granted -
US 12291557
Chimeric TIM4 receptors and uses thereof
granted -
US 12291560
Dimerizing agent regulated immunoreceptor complexes
granted -
US 12291556
Parathyroid hormone variants
granted -
US 12290588
Peptide having activity of improving skin condition and use thereof
granted -
WO 2025090898
ANTICORPS ANTI-RÉCEPTEUR DE LA TRANSFERRINE ET LEURS UTILISATIONS - RÉFÉRENCES CROISÉES AUX DEMANDES CONNEXES
granted -
WO 2025090858
PROCÉDÉS D'IDENTIFICATION DE VARIANTS DE CAPSIDE DE VAA AYANT DES CARACTÉRISTIQUES SOUHAITÉES
granted -
US 12285435
Multivesicular liposome formulations of dexamethasone
granted -
US 12285417
Methods for treating chronic obstructive pulmonary disease
granted -
US 12285424
Methods for treating neutropenia
granted -
US 12285419
Bupivacaine multivesicular liposome formulations and uses thereof
granted -
US 12286406
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted -
US 12285447
Methods and compositions for treating ulcerative colitis
granted -
US 12285496
Gene therapy for haploinsufficiency
granted -
US 12286407
Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases
granted -
US 12285460
Pharmaceutical compositions
granted -
US 12285392
Method for modulating metabolism
granted -
US 12285404
Prevention of rosacea inflammation
granted -
US 12285472
Self-antigen displaying nanoparticles targeting auto-reactive immune factors and uses thereof
granted -
US 12286431
Crystalline forms of a KRas G12C inhibitor
granted -
US 12285397
Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders
granted -
US 12285490
ASH1L degraders and methods of treatment therewith
granted -
US 12286480
Modulators of ROR1-ROR2 binding
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.